TEBRIVAN Trademark

Trademark Overview

On Wednesday, December 24, 2008, a trademark application was filed for TEBRIVAN with the United States Patent and Trademark Office. The USPTO has given the TEBRIVAN trademark a serial number of 77639998. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 25, 2013. This trademark is owned by Vertex Pharmaceuticals Incorporated. The TEBRIVAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of viral diseases, bacterial infections, cystic fibrosis, cancer, autoimmune diseases, inflammatory diseases, neurological disorders and epilepsy
tebrivan

General Information

Serial Number77639998
Word MarkTEBRIVAN
Filing DateWednesday, December 24, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 25, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 3, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of viral diseases, bacterial infections, cystic fibrosis, cancer, autoimmune diseases, inflammatory diseases, neurological disorders and epilepsy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 29, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, February 25, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 25, 2013ABANDONMENT - NO USE STATEMENT FILED
Friday, July 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 19, 2012EXTENSION 5 GRANTED
Tuesday, July 17, 2012EXTENSION 5 FILED
Tuesday, July 17, 2012TEAS EXTENSION RECEIVED
Friday, January 27, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 26, 2012EXTENSION 4 GRANTED
Tuesday, January 24, 2012EXTENSION 4 FILED
Tuesday, January 24, 2012TEAS EXTENSION RECEIVED
Wednesday, July 13, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 12, 2011EXTENSION 3 GRANTED
Friday, July 8, 2011EXTENSION 3 FILED
Friday, July 8, 2011TEAS EXTENSION RECEIVED
Wednesday, February 16, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 15, 2011EXTENSION 2 GRANTED
Wednesday, January 26, 2011EXTENSION 2 FILED
Tuesday, February 15, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 26, 2011TEAS EXTENSION RECEIVED
Thursday, July 22, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 20, 2010EXTENSION 1 GRANTED
Tuesday, July 20, 2010EXTENSION 1 FILED
Tuesday, July 20, 2010TEAS EXTENSION RECEIVED
Tuesday, January 26, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 3, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 3, 2009PUBLISHED FOR OPPOSITION
Monday, September 28, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 28, 2009ASSIGNED TO LIE
Thursday, September 17, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 15, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 15, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 15, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 17, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 17, 2009NON-FINAL ACTION E-MAILED
Tuesday, March 17, 2009NON-FINAL ACTION WRITTEN
Tuesday, March 17, 2009ASSIGNED TO EXAMINER
Monday, December 29, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

tebrivan diseases inflammatory cancer autoimmune neurological epilepsy disorders fibrosis cystic treatment